logo

For the Inventor, By the Inventor

Lafayette, CO, United States of America

Zhengbin Yao

This inventor holds 10 USPTO granted patents and 1 published patent application. Top assignee: Immunex Corporation. Active years: 1998-2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Zhengbin Yao. Retrieved from https://idiyas.com/inventor/zhengbin-yao

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10 

% Patents Active = 90.0

Average Co-Inventor Count = 3.1

ph-index = 7

Forward Citations = 202(Granted Patents)


Location History:

  • Seattle, WA (US) (1998)
  • Lafayette, CO (US) (1999 - 2008)

Company Filing History:

goldMedal10 out of 451 
 
Immunex Corporation
 patents

Years Active: 1998-2008

Loading Chart...
10 patents (USPTO):Explore Patents
1. 7432237 - Methods of treating asthma by administering interleukin-17 receptor (2008-10-07),
2. 7273843 - Methods of treating allergy by administering interleukin-17 receptor (2007-09-25),
3. 6680057 - Methods of treating autoimmune disease by administering interleukin-17 receptor (2004-01-20),
4. 6197525 - Assay kits for detection and methods of inhibiting IL-17 binding (2001-03-06),
5. 6100235 - Methods of treating immune and inflammatory response with IL-17 receptors (2000-08-08),
6. 6096305 - Receptor that binds IL-17 (2000-08-01),
7. 6072037 - Antibodies to the IL-17 receptor (2000-06-06),
8. 6072033 - Receptor that binds IL-17 (2000-06-06),
9. 5869286 - Receptor that binds IL-17 (1999-02-09),
10. 5716623 - Isolated Herpesvirus saimiri proteins that bind MHC Class II molecules (1998-02-10),

Title: Innovations by Zhengbin Yao in Asthma and Allergy Treatments

Introduction

Zhengbin Yao is a prominent inventor based in Lafayette, CO (US), known for his significant contributions to the field of immunology. He holds a total of 10 patents, focusing on methods to treat asthma and allergies through innovative pharmaceutical compositions.

Latest Patents

Yao's latest patents include groundbreaking methods of treating asthma by administering interleukin-17 receptors. These patents disclose isolated receptors for IL-17, along with the DNA encoding such receptors and the pharmaceutical compositions derived from them. The isolated receptors have the potential to regulate immune responses effectively. Additionally, he has developed methods for treating allergies using similar interleukin-17 receptors, further showcasing his expertise in this vital area of medical research.

Career Highlights

Zhengbin Yao is currently associated with Immunex Corporation, where he continues to advance his research and development efforts. His work has been instrumental in creating innovative solutions for managing immune-related conditions, particularly asthma and allergies.

Collaborations

Yao collaborates with notable colleagues, including Melanie K. Spriggs and William Christian Fanslow, III, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Zhengbin Yao's contributions to the field of immunology through his patents and collaborations highlight his commitment to improving treatments for asthma and allergies. His work continues to pave the way for advancements in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…